Solutions
Pricing
Log in
Teams
Get started
Log in
Get started
Germline Therapies - REBUTTAL
RH
by
ruben hyndal
·
2 views
·
Updated Aug 12, 2021
Share
Embed
Create your own
Chapters
00:00
Chapter 1
00:14
Chapter 2
00:37
Chapter 3
02:10
Chapter 4
02:19
Chapter 5
02:48
Chapter 6
03:00
Chapter 7
03:13
Chapter 8
03:47
Chapter 9
03:50
Chapter 10
03:59
Chapter 11
04:52
Chapter 12
05:20
Chapter 13
Audio Transcript
Auto-generated
00:03 - 00:07
The opposition maintains the belief that Germline therapies would eradicate
00:07 - 00:12
genetic disorders and diseases more effectively and time efficiently than
00:12 - 00:13
what is currently accessible.
00:14 - 00:18
It was mentioned that if medical science underwent further research
00:18 - 00:21
and development in the field of germline therapy, it could
00:21 - 00:24
be an option for treating genetic conditions very early on
00:25 - 00:28
with a particular focus on cancer and sickle cell disease.
00:29 - 00:32
The opposition discussed the benefits of using Germline therapy to
00:32 - 00:36
eradicate the genes that code for specific genetic disorders and
00:36 - 00:38
how the current methods of treatment are too time consuming
00:39 - 00:42
to which I say the extent of the extent of
00:42 - 00:46
which current cancer therapies of research and successful a time
00:46 - 00:49
consuming procedure would be the least of a patient's worries.
00:50 - 00:54
Whereas with Germline therapies, the time consuming nature and the
00:55 - 00:58
lack of medical knowledge will and should lead to patient
00:58 - 01:01
hesitance as the costly and time consuming method of curing
01:02 - 01:04
genetic disorders may not even work.
01:05 - 01:08
The opposition only covered the tip of the iceberg when
01:08 - 01:12
it comes down to overall practicality of the therapies it
01:12 - 01:16
was mentioned and encouraged that Germline therapies with the correct
01:16 - 01:19
research and funding put behind them could very well become
01:19 - 01:21
the new revolutionary medical breakthroughs.
01:23 - 01:26
Although this could indeed be the case from what research
01:26 - 01:27
has shown so far.
01:28 - 01:30
Even if the therapy did get to a point of
01:30 - 01:35
being used successfully on people completely risk free because of
01:35 - 01:39
the publicity involved with the commotion and connotations associated with
01:39 - 01:42
germline therapy, there would be a higher chance of people
01:43 - 01:45
opting out of germline therapy and sticking with the currently
01:46 - 01:46
available procedures.
01:48 - 01:52
Additionally, who is going to willingly put their money into
01:52 - 01:55
research and advancements of a therapy that in all its
01:55 - 01:59
years have possibly been the next scientific medical breakthrough has
01:59 - 02:02
shown no promise and in fact uncovered more reasons not
02:02 - 02:06
to go ahead with its progression at all, particularly when
02:06 - 02:09
there are already suitable methods being used to treat genetic
02:09 - 02:15
disorders. The opposition mentioned that 5-10% of cancers are heritable
02:15 - 02:17
that of which is true and is a very big
02:18 - 02:19
underlying issue all around the world.
02:20 - 02:25
There are in fact multiple, accessible cheek and successful methods
02:25 - 02:29
for managing and in some cases eradicating cancer cells from
02:29 - 02:32
the patient's body entirely, such as chemotherapy.
02:33 - 02:36
It was mentioned that the process of chemotherapy was very
02:36 - 02:37
time consuming.
02:37 - 02:41
And although the statement is true, the processes, success rates
02:41 - 02:45
and overall medical knowledge available on the outcomes is far
02:45 - 02:47
more reliable and accessible than germline therapy.
02:49 - 02:53
Cancer management and research, particularly in Australia, is heavily funded
02:53 - 02:56
by the government and we, as a country, holds one
02:56 - 02:58
of the highest rates in certain cancers and yet have
02:59 - 03:01
one of the lowest related mortality rates.
03:03 - 03:07
Chemotherapy uses anti cancer drugs often in combination with radiation
03:08 - 03:11
therapy and all surgery, but it can be used alone.
03:12 - 03:14
It just depends on the cancer type and the overall
03:14 - 03:15
severity of the situation.
03:17 - 03:21
Although as mentioned, chemotherapy is rather time consuming a level
03:21 - 03:24
of predictability held by professionals and the overall public accessibility
03:25 - 03:28
outweigh the time it takes for patients to undergo this
03:28 - 03:33
treatment. Human therapy also allows patients to personally elect for
03:33 - 03:36
treatment once they understand the ways that cancer may impact
03:36 - 03:37
and change their lives.
03:38 - 03:42
Not only is chemotherapy cheaper, more accessible and more reliable,
03:43 - 03:46
it does not hold the unethical powers that germline therapy
03:46 - 03:50
does. There is an idea that people with genetic disorders
03:50 - 03:55
and conditions are bedridden, incapable, miserable people in hospitals their
03:55 - 03:58
whole lives, although this can be the case with some
03:58 - 04:02
genetic disorders, Some, including sickle cell disease, do have their
04:03 - 04:08
benefits. Sickle cell disease affects the hemoglobin that carries oxygenated
04:08 - 04:12
red blood cells around the body for cellular respiration, causing
04:12 - 04:15
less oxygen to be carried to the extremities and organs
04:15 - 04:16
of the body.
04:17 - 04:20
The traditional by concave nature of red blood cells is
04:20 - 04:23
altered by sickle cell disease, which causes more hard, compact
04:24 - 04:27
and thin blood cells, which ultimately does affect the rate
04:27 - 04:31
of the human globe and carrying oxygen successfully sickle cell
04:31 - 04:34
disease. Although in and of itself isn't fatal.
04:35 - 04:37
Some complications that follow as a result of the disease
04:38 - 04:38
can be.
04:39 - 04:43
Although single self disease has possibly fatal implications, such as
04:43 - 04:46
strokes, it does actually have some benefits.
04:47 - 04:49
The benefits that come with sickle cell disease.
04:49 - 04:53
Our immunity to malaria As a result of this inherent
04:53 - 04:56
immunity to such a deadly disease that kills almost 409,000
04:57 - 05:01
people a year, according to the World Health Organization, there
05:01 - 05:04
is an incentive to stop genetic alteration of people with
05:05 - 05:05
sickle cell disease.
05:07 - 05:10
The benefit of not using Germline therapies to genetically edit
05:10 - 05:13
people with this disease is that they can be medically
05:13 - 05:16
examined to understand malaria further and possibly come up with
05:17 - 05:19
more options for increasing immunity around the world.
05:20 - 05:23
For all the reasons mentioned in this video and the
05:23 - 05:28
previous one, Germline therapy is to underdeveloped to introduce to
05:28 - 05:28
humans successfully.
05:30 - 05:33
Germline therapy should not be explored or introduced to medical
05:33 - 05:35
clinics or made publicly accessible.
05:36 - 05:41
This conclusion is reached through consideration of the costs, risks
05:41 - 05:46
involved, the overall unpredictability of outcome and the overarching possibility
05:46 - 05:47
of future genetic genocide.
05:50 - 05:54
Although the currently available methods of eradicating genetic disorders such
05:54 - 05:57
as cancer do need further development, they have got to
05:57 - 06:00
a point of success that is accessible to the public
06:00 - 06:03
and continues to be modified to increase success rates and
06:04 - 06:05
treatment plans as a whole.
06:06 - 06:10
In saying this, there are already multiple, suitable therapies and
06:10 - 06:13
management plans in place that we won no work to
06:14 - 06:17
maintain, affordable and accessible to the public, with minimal risks.
06:18 - 06:21
And three can be sought after by the patient, rather
06:21 - 06:24
than a non consensual and invasive procedure that affects their
06:24 - 06:26
life, Okay.
See full transcript